간편결제 가능보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
페니실린 및 스트렙토 마이신 시장. 페니실린과 스트렙토 마이신 시장 규모는 2027 년까지 29 억 달러에 달하는 것으로 추정되며 2022-2027 년 예측 기간 동안 CAGR 0.7%로 증가합니다. 페니실린과 스트렙토 마이신은 그람 음성 박테리아와 그람 양성 박테리아에 대한 강력한 결합 작용으로 인해 박테리아 감염을 치료하는 데 널리 사용되는 두 가지 항생제입니다
Summary
Penicillin and Streptomycin Market. Penicillin and Streptomycin Market size is estimated to reach $2.9 Billion by 2027, growing at a CAGR of 0.7% during the forecast period 2022-2027. Penicillin and Streptomycin are the two Antibiotics that are widely used in treating bacterial infections owing to their powerful combined action against gram-negative bacteria and gram-positive bacteria
Table of Contents
1. Penicillin And Streptomycin Market - Overview
1.1 Definitions and Scope
2. Penicillin And Streptomycin Market- Executive Summary
2.1 Market Revenue, Market Size & Key Trends
2.2 Key trends by Application
2.3 Key trends by Product type
2.4 Key trends by Manufacturing process
2.5 Key trends by Route of Administration
2.6 Key trends by End User
2.7 Key trends by Geography
3. Penicillin And Streptomycin Market– Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split by Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis
4. Penicillin And Streptomycin Market - Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters five force model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. Penicillin And Streptomycin Market– Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Penicillin And Streptomycin Market– By Application (Market Size – $Million/$Billion)
6.1 Throat Infections
6.2 Meningitis
6.3 Tuberculosis
6.4 Others.
7. Penicillin And Streptomycin Market– By Product Type (Market Size – $Million/$Billion)
7.1 Penicillin
7.2 Streptomycin
8. Penicillin And Streptomycin Market– By Manufacturing Process (Market Size – $Million/$Billion)
8.1 Penicillin
8.1.1 Natural
8.1.2 Synthetic
8.1.3 Semi-Synthetic
8.2 Streptomycin
8.2.1 Natural
8.2.2 Synthetic
8.2.3 Semi-Synthetic
9. Penicillin And Streptomycin Market– By Route of Administration (Market Size – $Million/$Billion)
9.1 Oral
9.2 Intramuscular
9.3 Intravenous
10. Penicillin And Streptomycin Market– By End User (Market Size – $Million/$Billion)
10.1 Hospital
10.2 Clinics
10.3 Others(Clinical laboratories)
11. Penicillin And Streptomycin Market- By Geography (Market Size – $Million/$Billion)
11.1 North America
11.1.1 U.S.
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 U.K.
11.2.2 Germany
11.2.3 France
11.2.4 Italy
11.2.5 Spain
11.2.6 Rest of Europe
11.3 Asia-Pacific
11.3.1 China
11.3.2 India
11.3.3 Japan
11.3.4 South Korea
11.3.5 Australia & New Zealand
11.3.6 Rest of Asia-Pacific
11.4 Rest of the World
11.4.1 Middle East
11.4.2 Africa
11.4.3 South America
12. Penicillin And Streptomycin Market - Entropy
13. Penicillin And Streptomycin Market Company Analysis
13.1 Pfizer, Inc
13.2 GlaxoSmithKline Plc
13.3 Johnson & Johnson
13.4 Lonza AG
13.5 Novartis Healthcare
13.6 Merck & Co
13.7 Dr Reddy Laboratories
13.8 Takeda Pharmaceutical Company Ltd
13.9 Astellas Pharma Inc
13.10 Eli Lilly and company
"*Financials for private companies would be provided on a best efforts basis”.
세금계산서 발행 문의
T. 070 8015 5940
보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
페니실린 및 스트렙토 마이신 시장. 페니실린과 스트렙토 마이신 시장 규모는 2027 년까지 29 억 달러에 달하는 것으로 추정되며 2022-2027 년 예측 기간 동안 CAGR 0.7%로 증가합니다. 페니실린과 스트렙토 마이신은 그람 음성 박테리아와 그람 양성 박테리아에 대한 강력한 결합 작용으로 인해 박테리아 감염을 치료하는 데 널리 사용되는 두 가지 항생제입니다
Summary
Penicillin and Streptomycin Market. Penicillin and Streptomycin Market size is estimated to reach $2.9 Billion by 2027, growing at a CAGR of 0.7% during the forecast period 2022-2027. Penicillin and Streptomycin are the two Antibiotics that are widely used in treating bacterial infections owing to their powerful combined action against gram-negative bacteria and gram-positive bacteria
Table of Contents
1. Penicillin And Streptomycin Market - Overview
1.1 Definitions and Scope
2. Penicillin And Streptomycin Market- Executive Summary
2.1 Market Revenue, Market Size & Key Trends
2.2 Key trends by Application
2.3 Key trends by Product type
2.4 Key trends by Manufacturing process
2.5 Key trends by Route of Administration
2.6 Key trends by End User
2.7 Key trends by Geography
3. Penicillin And Streptomycin Market– Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split by Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis
4. Penicillin And Streptomycin Market - Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters five force model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. Penicillin And Streptomycin Market– Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Penicillin And Streptomycin Market– By Application (Market Size – $Million/$Billion)
6.1 Throat Infections
6.2 Meningitis
6.3 Tuberculosis
6.4 Others.
7. Penicillin And Streptomycin Market– By Product Type (Market Size – $Million/$Billion)
7.1 Penicillin
7.2 Streptomycin
8. Penicillin And Streptomycin Market– By Manufacturing Process (Market Size – $Million/$Billion)
8.1 Penicillin
8.1.1 Natural
8.1.2 Synthetic
8.1.3 Semi-Synthetic
8.2 Streptomycin
8.2.1 Natural
8.2.2 Synthetic
8.2.3 Semi-Synthetic
9. Penicillin And Streptomycin Market– By Route of Administration (Market Size – $Million/$Billion)
9.1 Oral
9.2 Intramuscular
9.3 Intravenous
10. Penicillin And Streptomycin Market– By End User (Market Size – $Million/$Billion)
10.1 Hospital
10.2 Clinics
10.3 Others(Clinical laboratories)
11. Penicillin And Streptomycin Market- By Geography (Market Size – $Million/$Billion)
11.1 North America
11.1.1 U.S.
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 U.K.
11.2.2 Germany
11.2.3 France
11.2.4 Italy
11.2.5 Spain
11.2.6 Rest of Europe
11.3 Asia-Pacific
11.3.1 China
11.3.2 India
11.3.3 Japan
11.3.4 South Korea
11.3.5 Australia & New Zealand
11.3.6 Rest of Asia-Pacific
11.4 Rest of the World
11.4.1 Middle East
11.4.2 Africa
11.4.3 South America
12. Penicillin And Streptomycin Market - Entropy
13. Penicillin And Streptomycin Market Company Analysis
13.1 Pfizer, Inc
13.2 GlaxoSmithKline Plc
13.3 Johnson & Johnson
13.4 Lonza AG
13.5 Novartis Healthcare
13.6 Merck & Co
13.7 Dr Reddy Laboratories
13.8 Takeda Pharmaceutical Company Ltd
13.9 Astellas Pharma Inc
13.10 Eli Lilly and company
"*Financials for private companies would be provided on a best efforts basis”.
